Related Experiment Videos
[Paraneoplastic limbic encephalitis in small cell lung carcinoma]
B Fischer1, P Kalden, P P Urban
1III. Medizinische Klinik und Poliklinik, Hämatologie-Onkologie-Pneumologie, Klinikum der Johannes Gutenberg-Universität, Mainz. b.fischer@3-med.klinik.uni-mainz.de
Pneumologie (Stuttgart, Germany)
|May 27, 2004
Summary
A 63-year-old male with small cell lung carcinoma (SCLC) developed paraneoplastic limbic encephalitis. Despite treatment, severe neurological deficits persisted, highlighting challenges in managing this rare autoimmune complication.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Small cell lung carcinoma (SCLC) can present with rare neurological complications.
- Paraneoplastic syndromes occur when cancer triggers an immune response affecting the nervous system.
Observation:
- A patient with SCLC presented with acute confusion and MRI-confirmed temporal lobe abnormalities.
- Cerebrospinal fluid and serum revealed the presence of anti-Hu antibodies, indicative of an autoimmune process.
Findings:
- The patient was diagnosed with paraneoplastic limbic encephalitis associated with SCLC.
- Treatment with chemotherapy and corticosteroids showed partial response in the tumor but limited improvement in neurological symptoms.
Implications:
- This case underscores the importance of recognizing paraneoplastic limbic encephalitis in SCLC patients with neurological symptoms.
- The findings suggest that while primary tumor treatment is crucial, neurological recovery may be suboptimal, necessitating further research into advanced therapeutic strategies.